Monarch Medical Technologies and Voluntis to Host Webinar on Use of Technology to Support Inpatient and Outpatient Insulin Management
Monarch Medical Technologies and Voluntis to Host June 25th Webinar to Discuss Best Practices for Initiating and Managing Insulin Therapy Across the Continuum of Care.
Monarch Medical Technologies Announces New Insulin-on-Board Adjustment for Subcutaneous Insulin Dosing
Monarch’s EndoTool® SubQ to feature optional insulin-on-board (IOB) calculation for subcutaneous insulin to mitigate the risk of hypoglycemia.
Monarch Medical Technologies to Participate in the American Diabetes Association’s 79th Scientific Sessions and DiabetesMine D-Data ExChange
Monarch will be participating in the DiabetesMine D-Data ExChange on June 7th, 2019 and the American Diabetes Association’s 79th Scientific Sessions on June 7-11, 2019 in San Francisco, CA.
Inpatient diabetes management expert, Caroline Isbey, RN, MSN, joins Monarch to serve as the clinical education manager.
Retrospective Analysis Produced by Monarch Medical Technologies Explores the Effect of Blood Glucose Goal Range and Two-Hour Blood Glucose Checks on Hypoglycemia Incidence
Two Posters Presented at AACE 2019 Review the Safety and Efficacy of Blood Glucose Goal Range and Two-Hour Blood Glucose Checks for Intravenous Insulin Dosing.
Bruce Lisanti, an experienced senior level executive in healthcare, technology and services industries, has been named president and chief executive officer of Monarch.
The complimentary webinar features Dr. Sandy Fogel of Carilion Clinic discussing glycemic management quality improvement in preparation for new quality metrics.